Jojan Inc – Trademark Portfolio

Entity Type: 03

Jojan Inc holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include 7 X 7 STRATEGY, 10/4/2 STRATEGY, and WHO WILL YOU BECOME?. The owner is based in Delray Beach, FL.

Ste 211

160 Congress Park Drive

Delray Beach, FL 33445

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jojan Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (7 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Jojan Inc have?

Jojan Inc has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 3 cancelled.

What trademark classes does Jojan Inc file in?

Jojan Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Jojan Inc's most well-known trademarks?

Jojan Inc's registered trademark portfolio includes well-known marks such as 7 X 7 STRATEGY, 10/4/2 STRATEGY, and WHO WILL YOU BECOME?. These are among 3 currently registered trademarks in the portfolio.

What is Jojan Inc's trademark registration success rate?

Jojan Inc has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.